Furthermore, we aimed to investigate whether topical corticosteroid (TCS) treatment, AD disease severity and AD risk factors (filaggrin gene (FLG) mutations and S. aureus colonisation) were associated with changes in the eukaryotic microbial community. This evidence concerns the gene FLG and Alzheimer disease.